Moreover, this observation is in contrast with previous studies on young breast cancer patients, where the second most prevalent gene identified was BRCA2, exhibiting rates comparable to those of BRCA1 [22,29,30]. The gene discussed is BRCA1; the disease is breast carcinoma.